[1]
E. Manalu, A. Winanda, and D. E. J. Luhulima, “C-Reactive Protein (CRP) Medium and Severe Symptoms Levels of COVID-19”, J. Drug Delivery Ther., vol. 12, no. 6, pp. 152–156, Nov. 2022, doi: 10.22270/jddt.v12i6.5687.